| Literature DB >> 24102752 |
R Vos1, S E Verleden, D Ruttens, E Vandermeulen, J Yserbyt, L J Dupont, D E Van Raemdonck, N De Raedt, O Gheysens, P A De Jong, G M Verleden, B M Vanaudenaerde.
Abstract
This case report describes the evolution of pulmonary function findings (FVC, FEV1 and TLC) and CT features with pirfenidone treatment for restrictive allograft syndrome following lung transplantation. Furthermore, we herein report hypermetabolic activity on (18) F-FDG PET imaging in this setting, which could indicate active fibroproliferation and pleuroparenchymal remodeling. These findings may warrant further investigation. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: Fibrosis; lung transplantation; pirfenidone; restrictive allograft syndrome
Mesh：
Substances：
Year: 2013 PMID： 24102752 DOI： 10.1111/ajt.12474
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086